Research Article | Volume 3 Issue 11 (2025) | Published in 2025-11-18
Pathochemical and Clinical Chemistry Assessment of Biochemical Determinants Associated with Hemorrhagic Fever Patients Under Surgical and Anesthetic Management in Dhi Qar Province, Iraq
-
Abstract
One of the most dangerous viral diseases, hemorrhagic fever affects several organ systems and frequently results in potentially fatal consequences such coagulation problems, liver failure, and electrolyte abnormalities. In order to improve treatment plans and reduce related risks, it is essential to comprehend the physiological and chemical changes that take place in patients with this illness, particularly during surgery or anesthesia. In order to find biomarkers that could aid in better patient care, this study examined the biochemical and clinical alterations in hemorrhagic fever patients having surgery or anesthesia in the Dhi Qar Governorate of Iraq. 48 hemorrhagic fever patients who underwent thorough biochemical and hematological testing were included in the study. These studies included serum electrolyte values, coagulation tests (PT, INR, PTT), liver function tests (ALT, AST, ALP), and kidney function tests (urea, creatinine). To guarantee the correctness of the findings, the analyses were carried out using conventional laboratory methods. In addition to lower platelet counts and salt levels, the data revealed statistically significant increases in liver enzymes and coagulation markers, indicating systemic metabolic and pharmacological disruptions. Significant alterations in some organ function markers were also noted, highlighting the significance of ongoing observation of these factors throughout therapy and surgical procedures. Thus, our study shows that thorough biochemical evaluation is essential for getting hemorrhagic fever patients ready for surgery and anesthesia, which lowers complications and improves clinical results.
Keywords: Hemorrhagic Fever; Pathochemical Assessment; Surgical Management; Liver Enzymes.
-
References
[1] Al-Ani, F. A., & Al-Azzawi, T. M., “Biochemical Markers in Hemorrhagic Fever Diagnosis and Management,” Journal of Clinical Virology, vol. 129, pp. 104477, 2020, https://doi.org/10.1016/j.jcv.2020.104477.
[2] Zhang, Y., et al., “Pathophysiology and Biochemical Alterations in Hemorrhagic Fever: A Systematic Review,” Frontiers in Medicine, vol. 7, pp. 617294, 2020, https://doi.org/10.3389/fmed.2020.617294.
[3] Lee, S., & Kim, H., “Clinical Chemistry Biomarkers for Hemorrhagic Fever: Diagnostic and Prognostic Value,” Analytical Chemistry, vol. 92, no. 19, pp. 13455–13463, 2020, https://doi.org/10.1021/acs.analchem.0c02289.
[4] Patel, R., et al., “Serum Biochemical Changes in Viral Hemorrhagic Fever Patients,” Viruses, vol. 12, no. 12, pp. 1384, 2020, https://doi.org/10.3390/v12121384.
[5] Garcia, A., et al., “Assessment of Hematological and Biochemical Parameters in Hemorrhagic Fever,” Biochemical Genetics, vol. 58, pp. 131–146, 2020, https://doi.org/10.1007/s10528-020-09964-8.
[6] Sarhan, Y. T., Yahyaa, B. T., & Abdul-Fatah, B. N. (2025). Reproductive health and family planning patterns among women aged 15–45 in Al-Ramadi Province, Iraq. Ibn Sina Journal of Medical Science, Health & Pharmacy, 3(10), 1–11. https://doi.org/10.64440/IBNSINA/SINA005
[7] Nguyen, T. T., et al., “Biochemical and Immunological Profiles in Dengue and Hemorrhagic Fever,” PLoS ONE, vol. 15, no. 8, e0237361, 2020, https://doi.org/10.1371/journal.pone.0237361.
[8] Al-Baghdadi, F. A. N. (2025). Interobserver and intraobserver variability in CT scan reporting of liver hydatid cyst staging and location. Ibn Sina Journal of Medical Science, Health & Pharmacy, 3(11), 1–8. https://doi.org/10.64440/IBNSINA/SINA007
[9] Ibrahim, M., et al., “Biochemical Markers and Outcomes in Hemorrhagic Fever Patients,” Infectious Diseases Reports, vol. 12, no. 3, e894, 2020, https://doi.org/10.3390/idr12030023.
[10] Li, W., et al., “Role of Cytokines and Biochemical Markers in Hemorrhagic Fever Severity,” Scientific Reports, vol. 10, 2020, Article 11688, https://doi.org/10.1038/s41598-020-68709-8.
[11] Oliveira, D. S., et al., “Biochemical and Hematological Profiles in Hemorrhagic Fever Cases in Brazil,” PLoS Neglected Tropical Diseases, vol. 14, no. 2, e0007982, 2020, https://doi.org/10.1371/journal.pntd.0007982.
[12] Wu, J., et al., “Biochemical Changes during Hemorrhagic Fever Infection in Murine Models,” Frontiers in Immunology, vol. 11, 2021, pp. 626113, https://doi.org/10.3389/fimmu.2021.626113.
[13] Marhoon, A. A., & Hussein, S. A. (2025). Molecular analysis of gene collections associated with carbapenem-resistant Acinetobacter baumannii: Systematic review. Ibn Sina Journal of Medical Science, Health & Pharmacy, 3(8), 1–8. https://doi.org/10.64440/IBNSINA/SINA003.
[14] Wang, H., & Zhang, K., “Evaluation of Liver and Kidney Function Tests in Hemorrhagic Fever,” Journal of Clinical Laboratory Analysis, vol. 35, no. 3, e23655, 2021, https://doi.org/10.1002/jcla.23655.
[15] Rahman, M., et al., **“Biochemical and Hematological Alterations in Hemorrhagic Fever Patients,”** Journal of Medical Virology, vol. 93, no. 4, pp. 2298–2306, 2021, https://doi.org/10.1002/jmv.26284.
-
Article history_en
Received : Nov 05, 2025
Revised : Nov 06, 2025
Accepted : Nov 04, 2025
-
Authors Affiliations_en
AZHER ADNAN HIAL, ABDULHUSSEIN SEGEEL ASHOUR, ANWAR JASIB ALMZAIEL, NASHWAN QAHTAN JABBAR
-
Ethics declarations_en
Acknowledgment None Author Contribution All authors contributed equally to the main contributor to this paper. All authors read and approved the final paper. Conflicts of Interest “The authors declare no conflict of interest.” Funding “This research received no external funding”
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 The AuthorsHow to cite
